A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus-Reference-Cited by-同舟云学术

A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus

Published:2022-07 Issue:4 Volume:21 Page:721-724
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Szentpetery Sylvia^ORCID,Foil Kimberly^ORCID,Hendrix Sara^ORCID,Gray Sue,Mingora Christina^ORCID,Head Barbara,Johnson Donna,Flume Patrick A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference17 articles.

1. Annual Data Report [Internet]. Cystic Fibrosis Foundation. 2020.

2. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del);Southern;Cochrane Database Syst Rev,2020

3. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study;Davies;Lancet Respir Med,2016

4. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study;Rosenfeld;Lancet Respir Med,2018

5. Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy;Fortner;J Cyst Fibros,2021

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic in utero gene editing as a treatment for cystic fibrosis;2024-09-08

2. Advances in Care and Outcomes for Children with Cystic Fibrosis;Clinics in Chest Medicine;2024-09

3. Cystic fibrosis;Nature Reviews Disease Primers;2024-08-08

4. Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies;Journal of Cystic Fibrosis;2024-06

5. Extent of foetal exposure to maternal elexacaftor/tezacaftor/ivacaftor during pregnancy;British Journal of Pharmacology;2024-05-21